KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Exelixis, Inc. (NASDAQ:EXEL) hit a new 52-week high on Monday . The company traded as high as $27.08 and last traded at $26.58, with a volume of 98687 shares. The stock had previously closed at $26.53
Exelixis (EXEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exelixis (EXEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) AstraZeneca plc (NYSE: AZN...
EULAV Asset Management boosted its position in shares of Exelixis, Inc. (NASDAQ:EXEL) by 16.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm own
Exelixis, Inc. (NASDAQ:EXEL) EVP Patrick J. Haley sold 5,000 shares of the firm’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $26.00, for a total transa
Exelixis, Inc. (NASDAQ:EXEL) Director George A. Scangos sold 15,000 shares of the stock in a transaction that occurred on Friday, April 24th. The shares were sold at an average price of $26.24, for a

2 Oncology Names That Are 'En Fuego'

08:59pm, Monday, 27'th Apr 2020
Today, we update the investment thesis on two oncology concerns whose stocks have been on fire here in April despite the continued COVID-19 outbreak. We recap w
EXEL vs. RGEN: Which Stock Is the Better Value Option?

Stocks That Hit 52-Week Highs On Monday

02:21pm, Monday, 27'th Apr 2020
During Monday's morning session, these companies made new 52-week highs. Noteworthy Points: The largest company by market cap to set a new 52-week high was Novo Nordisk...
Exelixis, Inc. (NASDAQ:EXEL) has been assigned an average recommendation of “Buy” from the seventeen analysts that are presently covering the company, MarketBeat.com reports. Five research analyst
Exelixis, Inc. (NASDAQ:EXEL) CMO Gisela Schwab sold 100,000 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $26.00, for a total tr
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE